Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15210 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28334257 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL27576571 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL28296193 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL28785215 | 0.95 | — | — | |
| Bromide SCHEMBL28065186 | 0.95 | ALDH1A1 (0.33) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL11434959 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL9482001 | 0.95 | ALDH1A1 (0.33) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28042039 | 0.95 | — | — | |
| SCHEMBL11406677 | 0.94 | ALDH1A1 (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029718-B2 | Process for production of essentially pure delta-9-tetrahydrocannabinol | CCT SCIENCES, LLC (US) | 2024-07-09 | — | — | US | claimed |
| CN-118047817-A | Biphenyl bridged dual-active-center metallocene complex and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-118047806-A | Preparation method and application of NN-bidentate coordination metal catalyst based on quinoline skeleton | 青岛科技大学 | 2024-05-17 | — | — | CN | claimed |
| CN-114853930-B | Synthesis of NNO-coordinated titanium zirconium hafnium metal catalyst and application of NNO-coordinated titanium zirconium hafnium metal catalyst in preparation of polyolefin elastomer | 青岛科技大学 | 2024-03-01 | — | — | CN | claimed |
| CN-114029091-B | Dual ligand catalytic system for ethylene selective trimerization, preparation method and application thereof | 浙江智英石化技术有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-117362329-A | Preparation method and application of NNO tridentate coordination metal catalyst based on quinoline skeleton | 青岛科技大学 | 2024-01-09 | — | — | CN | claimed |
| US-20240002358-A1 | Optically clear, taste-masked, shelf-stable nano-emulsions containing cannabinoids | CCT SCIENCES, LLC | 2024-01-04 | — | — | US | claimed |
| CN-117003797-A | Alpha-diimine metal complex with tetracene skeleton and preparation method and application thereof | 中国石化扬子石油化工有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-116768941-A | Alpha-diimine metal complex and preparation method and application thereof | 中国石化扬子石油化工有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-116640243-A | Method for synthesizing bimodal polyethylene by one-pot method | 青岛科技大学 | 2023-08-25 | — | — | CN | claimed |
| CN-113248548-A | Preparation method and application of single metallocene catalyst | 青岛科技大学 | 2021-08-13 | — | — | CN | claimed |
| CN-113087825-A | Preparation of bimetallic catalyst based on anthracene skeleton and application of bimetallic catalyst in high-temperature solution polymerization of olefin | 青岛科技大学 | 2021-07-09 | — | — | CN | claimed |
| CN-111196824-A | Preparation of anthracene skeleton phosphorus-nitrogen coordination bimetallic compound and ethylene selective oligomerization catalysis thereof | 青岛科技大学 | 2020-05-26 | — | — | CN | claimed |
| CN-110698513-A | Preparation of trihydroquinoline amine metal compound and application of trihydroquinoline amine metal compound in high-temperature solution polymerization of olefin | 青岛科技大学 | 2020-01-17 | — | — | CN | claimed |
| CN-102766128-A | Process for production of delta-9-tetrahydrocannabinol | AMR TECHNOLOGY INC | 2012-11-07 | — | — | CN | claimed |
| US-7674922-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-09 | — | — | US | claimed |
| CN-101316832-A | Method for producing delta-9-tetrahydrocannabinol | AMR TECHNOLOGY INC (US) | 2008-12-03 | — | — | CN | claimed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | claimed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | CNR2, CNR1, HRH4 | ALDH1A1 2849/4885 |
| US-20240002358-A1 | Optically clear, taste-masked, shelf-stable nano-emulsions containing cannabinoids | CNR2, CNR1, TAS2R10 | ALDH1A1 1784/4885 |
| US-12029718-B2 | Process for production of essentially pure delta-9-tetrahydrocannabinol | CNR2, CNR1, DAGLA | ALDH1A1 1983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.